Vincerx Pharma Presents Preclinical Data on VIP943 in Acute
Vincerx’s proprietary payload and linker technology and VIP943, a novel anti-CD123 antibody drug conjugate (ADC), demonstrated superiority with significant...
Source: globenewswire.com
Stay updated with breaking news from Vincerx Celltrapper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vincerx’s proprietary payload and linker technology and VIP943, a novel anti-CD123 antibody drug conjugate (ADC), demonstrated superiority with significant...